{"id":6923,"date":"2022-06-20T11:26:18","date_gmt":"2022-06-20T09:26:18","guid":{"rendered":"https:\/\/www.gkm-therapieforschung.de\/?post_type=tribe_events&p=6923"},"modified":"2022-06-21T18:39:10","modified_gmt":"2022-06-21T16:39:10","slug":"webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german","status":"publish","type":"tribe_events","link":"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/","title":{"rendered":"Webinar: EU Clinical Trial Regulation 536\/2014 (CTR): Was ist bei der Umsetzung zu beachten?"},"content":{"rendered":"

In German language:<\/p>\n

Seit dem 31.01.2022 ist die Clinical Trial Regulation 536\/2014 (CTR) in der Praxis anwendbar. Es gibt eine \u00dcbergangsfrist von drei Jahren, in der sowohl die EU Richtlinie 2001\/20 als auch die EU Verordnung 536\/2014 parallel laufen. Dieses praxisorientierte Webinar richtet sich an Sponsoren, die sich Klarheit \u00fcber die wichtigsten \u00c4nderungen und Anforderungen im Rahmen der EU CTR sowie der \u00dcbergangsphase verschaffen wollen. Zudem bietet es die Chance, Fragen zu stellen und sich auszutauschen.<\/p>\n

Anmeldung hier:<\/p>\n

https:\/\/forms.gle\/ztAKmpgVACiq36sy9<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

In German language: Seit dem 31.01.2022 ist die Clinical Trial Regulation 536\/2014 (CTR) in der Praxis anwendbar. Es gibt eine \u00dcbergangsfrist von drei Jahren, in der sowohl die EU Richtlinie 2001\/20 als auch die EU Verordnung 536\/2014 parallel laufen.<\/p>\n","protected":false},"author":37,"featured_media":0,"template":"","meta":{"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[],"tribe_events_cat":[1986],"class_list":["post-6923","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-online-seminar-2","cat_online-seminar-2"],"yoast_head":"\nWebinar: EU Clinical Trial Regulation 536\/2014 (CTR): Was ist bei der Umsetzung zu beachten? - GKM Gesellschaft f\u00fcr Therapieforschung mbH | Full-service CRO<\/title>\n<meta name=\"description\" content=\"Since 31.01.2022 the Clinical Trial Regulation 536\/2014 (CTR) is applicable in practice. There is a transition period of three years during which both EU Directive 2001\/20 and EU Regulation 536\/2014 run in parallel.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar: EU Clinical Trial Regulation 536\/2014 (CTR): Was ist bei der Umsetzung zu beachten? - GKM Gesellschaft f\u00fcr Therapieforschung mbH | Full-service CRO\" \/>\n<meta property=\"og:description\" content=\"Since 31.01.2022 the Clinical Trial Regulation 536\/2014 (CTR) is applicable in practice. There is a transition period of three years during which both EU Directive 2001\/20 and EU Regulation 536\/2014 run in parallel.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/\" \/>\n<meta property=\"og:site_name\" content=\"GKM Gesellschaft f\u00fcr Therapieforschung mbH | Full-service CRO\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-21T16:39:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gkm-therapieforschung.de\/wp-content\/uploads\/2019\/11\/gkm-gesellschaft-fuer-therapieforschung.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#organization\",\"name\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/wp-content\/uploads\/2019\/11\/gkm-gesellschaft-fuer-therapieforschung.jpg\",\"width\":1200,\"height\":630,\"caption\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH\"},\"image\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#website\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/\",\"name\":\"GKM Gesellschaft f\\u00fcr Therapieforschung mbH | Full-service CRO\",\"description\":\"Clinical Research Organization f\\u00fcr Auftragsforschung, klinische Studien und nicht-interventionelle Studien f\\u00fcr die Pharma und Medizinprodukte Industrie\",\"publisher\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.gkm-therapieforschung.de\/en\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/#webpage\",\"url\":\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/\",\"name\":\"Webinar: EU Clinical Trial Regulation 536\/2014 (CTR): Was ist bei der Umsetzung zu beachten? - GKM Gesellschaft f\\u00fcr Therapieforschung mbH | Full-service CRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.gkm-therapieforschung.de\/en\/#website\"},\"datePublished\":\"2022-06-20T09:26:18+00:00\",\"dateModified\":\"2022-06-21T16:39:10+00:00\",\"description\":\"Since 31.01.2022 the Clinical Trial Regulation 536\/2014 (CTR) is applicable in practice. There is a transition period of three years during which both EU Directive 2001\/20 and EU Regulation 536\/2014 run in parallel.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.gkm-therapieforschung.de\/en\/event\/webinar-eu-clinical-trial-regulation-536-2014-ctr-what-to-consider-during-implementation-in-german\/\"]}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","_links":{"self":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/users\/37"}],"version-history":[{"count":5,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6923\/revisions"}],"predecessor-version":[{"id":6930,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events\/6923\/revisions\/6930"}],"wp:attachment":[{"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/media?parent=6923"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tags?post=6923"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/www.gkm-therapieforschung.de\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=6923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}